Sensitising event in pregnancy (anti-D)
Rhesus prophylaxis · Obstetric
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Any potentially sensitising event (bleeding, trauma, ECV, miscarriage, procedures) in a Rhesus-negative woman risks feto-maternal haemorrhage and future haemolytic disease. Timely anti-D immunoglobulin (and a Kleihauer after 20 weeks) prevents sensitisation.
Assessment
Investigations
- Determine maternal Rhesus status
- Identify a potentially sensitising event
- Kleihauer test after ~20 weeks to quantify feto-maternal haemorrhage
Management
- Give anti-D immunoglobulin to non-sensitised Rh-negative women promptly (ideally within 72 h)
- Take a Kleihauer test after 20 weeks to guide the dose
- Manage the underlying event (bleeding/trauma)
- Document and arrange follow-up
- Liaise with obstetrics/transfusion
Drugs & doses
Anti-D immunoglobulin
Disposition
Obstetrics / transfusion.
Give anti-D promptly to a Rh-negative woman after any sensitising event, and take a Kleihauer after 20 weeks to size the dose.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.